Weaning transplant recipients from their immunosuppressive drugs

Transplant surgeons live in the hope that one day they will be able to wean at least some of their patients off the immunosuppressive drugs that must be taken to prevent rejection of a transplanted organ. A team of researchers led by Alberto Sánchez-Fueyo, at the University of Barcelona, Spain, has now identified markers that might make this possible for liver transplant recipients.

Transplant recipients must take immunosuppressive drugs for the rest of their lives to prevent of their transplanted organ; this has serious negative health consequences. It would be helpful if it were possible to determine what would happen if a patient was weaned from their immunosuppressive drugs: would they reject their transplanted organ or would their immune system be sufficiently tolerant of the transplant that it would not be rejected?

Sánchez-Fueyo and colleagues determined that liver with higher blood levels of proteins involved in handling iron (hepcidin and ferritin) could tolerate weaning from their . Moreover, measuring expression in the liver of genes involved in handling iron enabled Sánchez-Fueyo and colleagues to predict the outcome of immunosuppressive-drug withdrawal in an independent set of patients. They therefore suggest that they have identified a way to accurately pick out those recipients who would be good candidates for drug-weaning protocols.

Explore further

Substitution of brand name with generic drug proves safe for transplant recipients

More information: Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation, J Clin Invest. doi:10.1172/JCI59411
Provided by Journal of Clinical Investigation
Citation: Weaning transplant recipients from their immunosuppressive drugs (2011, December 12) retrieved 18 June 2021 from https://medicalxpress.com/news/2011-12-weaning-transplant-recipients-immunosuppressive-drugs.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments